MOMI PODS for Postpartum Health
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the MOMI PODS treatment for postpartum health?
What safety data exists for the MOMI PODS program for postpartum health?
The MOMI PODS program is designed to improve postpartum care by integrating it into pediatric care structures, focusing on increasing access to healthcare for postpartum individuals. While the program aims to mitigate maternal health risks, the available research does not provide specific safety data or adverse event information related to the program itself.14678
How is the MOMI PODS treatment different from other postpartum health treatments?
MOMI PODS is unique because it integrates postpartum care into pediatric care structures, improving access to primary care and community resources for postpartum individuals, especially those who are publicly insured. This approach focuses on mitigating maternal health risks by providing a collaborative care model involving multiple healthcare disciplines, which is not typically seen in standard postpartum care.19101112
What is the purpose of this trial?
The investigator's long-term goal is to mitigate pregnancy-related mortality (PRM) risk by systematically delivering integrated clinical and supportive care that is effective, equitable, and scalable. The investigator's central hypothesis is that the Multi-modal Maternal Infant Perinatal Outpatient Delivery System (MOMI PODS) will mitigate postpartum (PP) risk and reduce disparities in PP risk by improving biopsychosocial profiles and facilitating access to evidence-based clinical and supportive care. To test this hypothesis, the investigators will conduct a hybrid type 1 randomized controlled trial (RCT) of MOMI PODS versus enhanced usual care (EUC, which we will term MOMI CARE) among a total sample of 384 mother-infant dyads (192/group) following pregnancy affected by a cardiometabolic and/or mental health condition. The investigators will enroll participants on PP day 1 and collect data at baseline and 6 months and 1 year PP. The investigators will collect implementation and service data across sites.
Eligibility Criteria
The MOMI Study is for new mothers and their infants, specifically those affected by conditions like metabolic syndrome or postpartum depression/anxiety. Participants are enrolled on the first day after giving birth and will be followed up with at 6 months and 1 year postpartum.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either MOMI PODS or Enhanced Usual Care (EUC) interventions, focusing on postpartum care and reducing disparities in postpartum risk.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data collection at 6 months and 1 year postpartum.
Treatment Details
Interventions
- Enhanced Usual Care (EUC)
- MOMI PODS
MOMI PODS is already approved in United States for the following indications:
- Postpartum care for mothers with cardiometabolic and/or mental health conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor